🚧 ꡬ좕 쀑 β€” 데이터가 λΆ€μ •ν™•ν•  수 μžˆμŠ΅λ‹ˆλ‹€. 더 λ§Žμ€ κΈ°μ—…κ³Ό μ§€ν‘œλ₯Ό μΆ”κ°€ν•˜κ³  μžˆμŠ΅λ‹ˆλ‹€.

SLB N.V. vs Regeneron Pharmaceuticals, Inc.

μ‹œκ°„μ— λ”°λ₯Έ μ‹œκ°€μ΄μ•‘ 비ꡐ

SLB N.V.

$67.5B

μˆœμœ„ #238

Regeneron Pharmaceuticals, Inc.

$68.6B

μˆœμœ„ #236

μ‹œκ°„μ— λ”°λ₯Έ μ‹œκ°€μ΄μ•‘

μ£Όμš” μˆœκ°„

  • Regeneron Pharmaceuticals, Inc.이(κ°€) 2020λ…„κΉŒμ§€ SLB N.V.을(λ₯Ό) μΆ”μ›”ν–ˆμŠ΅λ‹ˆλ‹€

연도별 비ꡐ

연도SLB N.V.Regeneron Pharmaceuticals, Inc.선두
2026$67.5B$68.6BRegeneron Pharmaceuticals, Inc.
2025$56.3B$79.3BRegeneron Pharmaceuticals, Inc.
2024$54.6B$72.8BRegeneron Pharmaceuticals, Inc.
2023$72.4B$89.7BRegeneron Pharmaceuticals, Inc.
2022$73.1B$73.7BRegeneron Pharmaceuticals, Inc.
2021$40.5B$64.5BRegeneron Pharmaceuticals, Inc.
2020$28.8B$49.4BRegeneron Pharmaceuticals, Inc.
2019$50.9B$38.4BSLB N.V.
2018$43.4B$38.2BSLB N.V.
2017$78.6B$38.4BSLB N.V.
2016$95.3B$37.5BSLB N.V.
2015$77.6B$55.5BSLB N.V.
2014$92.3B$41.9BSLB N.V.
2013$95.9B$28.1BSLB N.V.
2012$72.9B$17.5BSLB N.V.
2011$70.7B$5.7BSLB N.V.
2010$85.4B$3.4BSLB N.V.
2009$65.7B$2.5BSLB N.V.
2008$41.9B$1.9BSLB N.V.
2007$96.5B$2.5BSLB N.V.
2006$61.4B$2.1BSLB N.V.
2005$46.8B$1.6BSLB N.V.
2004$31.9B$941.1MSLB N.V.
2003$25.8B$1.5BSLB N.V.
2002$19.5B$1.9BSLB N.V.
2001$25.1B$2.9BSLB N.V.
2000$36.0B$3.6BSLB N.V.
1999$22.2B$1.3BSLB N.V.
1998$18.1B$753.6MSLB N.V.
1997$31.0B$874.9MSLB N.V.
1996$19.0B$1.6BSLB N.V.
1995$12.9B$1.3BSLB N.V.
1994$9.2B$306.5MSLB N.V.